• 1. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indolecarboxylic acids and derivatives

Introduction to 5-chloro-4-fluoro-1H-indole-2-carboxylic acid (CAS No. 186446-26-4)

5-chloro-4-fluoro-1H-indole-2-carboxylic acid, identified by its CAS number 186446-26-4, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the indole family, which is well-known for its diverse biological activities and therapeutic potential. The presence of both chloro and fluoro substituents in its molecular structure enhances its pharmacological properties, making it a valuable scaffold for the development of novel drugs.

The structural features of 5-chloro-4-fluoro-1H-indole-2-carboxylic acid contribute to its unique chemical reactivity and biological interactions. The chloro group at the 5-position and the fluoro group at the 4-position introduce electronic and steric effects that can modulate the compound's binding affinity to biological targets. This makes it an attractive candidate for further exploration in drug discovery programs.

In recent years, there has been a growing interest in indole derivatives as potential therapeutic agents. The indole core is a privileged scaffold in medicinal chemistry, with numerous examples of indole-based drugs that have been successfully marketed. Among these, compounds with halogenated indole structures have shown promise in various therapeutic areas, including oncology, inflammation, and central nervous system disorders.

One of the most compelling aspects of 5-chloro-4-fluoro-1H-indole-2-carboxylic acid is its versatility as a building block for more complex molecules. The carboxylic acid functionality at the 2-position allows for further derivatization through amide bond formation, enabling the creation of a wide range of analogs with tailored pharmacological properties. This flexibility has made it a popular choice for medicinal chemists seeking to develop novel inhibitors or agonists.

Recent studies have highlighted the potential of halogenated indoles as kinase inhibitors. Kinases are enzymes that play a crucial role in many cellular processes, and their dysregulation is often associated with diseases such as cancer. By targeting specific kinases, halogenated indoles can modulate signaling pathways that are aberrantly activated in disease states. For instance, 5-chloro-4-fluoro-1H-indole-2-carboxylic acid has been investigated as a potential inhibitor of tyrosine kinases, which are overexpressed in many cancer cell lines.

The synthesis of 5-chloro-4-fluoro-1H-indole-2-carboxylic acid typically involves multi-step organic transformations starting from readily available precursors. Common synthetic routes include halogenation reactions followed by carboxylation to introduce the carboxylic acid group. The use of palladium-catalyzed cross-coupling reactions has also been reported to facilitate the introduction of fluorine atoms into the indole core.

The pharmacokinetic properties of 5-chloro-4-fluoro-1H-indole-2-carboxylic acid are another area of interest. Understanding how a compound is absorbed, distributed, metabolized, and excreted (ADME) is essential for assessing its potential as a drug candidate. Preliminary studies suggest that this compound exhibits favorable solubility and stability properties, which are critical factors for oral bioavailability.

In conclusion, 5-chloro-4-fluoro-1H-indole-2-carboxylic acid (CAS No. 186446-26-4) is a promising compound with significant potential in pharmaceutical research. Its unique structural features and biological activities make it an attractive scaffold for the development of novel therapeutic agents. As research continues to uncover new applications for halogenated indoles, compounds like this one are likely to play an increasingly important role in drug discovery and development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)